Sign In
Buy CODX
$1.44
-0.120 (-7.69%)
At Close: Jul 31, 2026
Co-Diagnostics Reports Fourth-Quarter and Full-Year 2020 Financial Results
04:01pm, Thursday, 25'th Mar 2021
SALT LAKE CITY, March 25, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests
Co-Diagnostics Stock Is an Out-and-Out Buy Before the Earnings Release
11:20am, Thursday, 25'th Mar 2021
CODX stock's true value isn't fully appreciated by the investing community, and this could provide a setup for an explosive move. The post Co-Diagnostics Stock Is an Out-and-Out Buy Before the Earning
Co-Diagnostics, Inc. Announces Fourth-Quarter and Full-Year 2020 Earnings Release Date and Webcast
08:30am, Thursday, 18'th Mar 2021
SALT LAKE CITY, March 18, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,
Co-Diagnostics: A+ Student Faces New Tests
10:45am, Friday, 12'th Mar 2021
Co-Diagnostics: A+ Student Faces New Tests
Biotech Stocks: What Will 2021 Look Like?
06:00am, Friday, 12'th Mar 2021
2020 was a wild run for the biotech sector, with COVID-19 dominating the headlines. What will happen this year?
Co-Diagnostics is designing at-home coronavirus PCR saliva test delivering results by smartphone app
03:50pm, Tuesday, 02'nd Mar 2021
Co-Diagnostics Inc (NASDAQ:CODX) has announced the development of a new at-home PCR-based coronavirus (COVID-19) testing, screening and surveillance platform that delivers rapid results via smartphone
Co-Diagnostics designs at-home coronavirus PCR saliva test delivering results by smartphone app
12:01pm, Tuesday, 02'nd Mar 2021
Co-Diagnostics Inc (NASDAQ:CODX) has announced the development of a new at-home PCR-based coronavirus (COVID-19) testing, screening and surveillance platform that delivers rapid results via smartphone
Co-Diagnostics notes its CoPrimer technology powers coronavirus saliva test now available through Walgreens digital health platform
10:23am, Thursday, 25'th Feb 2021
Co-Diagnostics Inc (NASDAQ:CODX) has confirmed that its patented CoPrimer technology is part of a coronavirus (COVID-19) saliva test that is now available through Walgreens Find Care, a digital healt
Why Co-Diagnostics Stock Is Shooting Higher Today
03:22pm, Wednesday, 24'th Feb 2021
Its technology underpins a coronavirus test that's about to get much wider distribution.
Co-Diagnostics' CoPrimer technology powers coronavirus saliva test now available through Walgreens digital health platform
11:46am, Wednesday, 24'th Feb 2021
Co-Diagnostics Inc (NASDAQ:CODX) patented CoPrimer technology is part of a coronavirus (COVID-19) saliva test that is now available through Walgreens Find Care, a digital health platform on the retail
Co-Diagnostics Names New CFO and CSO
08:36pm, Tuesday, 23'rd Feb 2021
With the latter appointment, the company's founder moves into a more advisory role.
Co-Diagnostics appoints long-time executive Brian Brown as its new chief financial officer
10:32am, Tuesday, 23'rd Feb 2021
Co-Diagnostics Inc (NASDAQ:CODX) announced Tuesday the appointment of Brian Brown as the company's new chief financial officer (CFO). The company said Brown's previous experience includes CFO, vice pr
Co-Diagnostics, Inc. Announces New Chief Financial Officer
09:30am, Tuesday, 23'rd Feb 2021
SALT LAKE CITY, Feb. 23, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced t
Co-Diagnostics to present on direct saliva testing at Molecular Medicine Tri-Conference
11:03am, Tuesday, 16'th Feb 2021
Co-Diagnostics Inc (NASDAQ:CODX) has said it will be presenting on direct saliva testing for coronavirus (COVID-19) at the 28th Annual International Molecular Medicine Tri-Conference, to be held virtu
CODX Stock Price Increased Over 80% This Past Month: Why It Happened
02:15pm, Tuesday, 09'th Feb 2021
The stock price of Co-Diagnostics Inc (NASDAQ: CODX) is up over 80% over the past month. This is why it happened.
